Developer docs
API playgroundTry for free, no card

Search company profiles

DNA‑Technology

Full company profile

uuid00rsdfn

Namestring
DNA‑Technology
Legal namestring
DNA-Technology LLC
Company typeenum
Private
Founded yearint
1993
Descriptiontext

DNA-Technology LLC is a Moscow-based molecular diagnostics manufacturer founded in 1993 that develops, produces, and supplies PCR equipment, instruments, and consumables for clinical and research applications. The company serves clinical diagnostic laboratories, medical institutions and hospitals, and scientific research institutions, with a coverage of more than 50 distributors worldwide across Russia, Central Asia, Mongolia, and other regions. Its primary technology is polymerase chain reaction (PCR), including real-time PCR and LAMP (loop-mediated isothermal amplification), complemented by DNA/RNA extraction methodologies.

Short descriptiontext

DNA-Technology is a Moscow-based molecular diagnostics manufacturer founded in 1993 that develops real-time PCR instruments, laboratory automation systems, and over 100 PCR/LAMP reagent kits for clinical diagnostic laboratories, hospitals, and research institutions across more than 50 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMoscow, Russia
HQ citystring
Moscow
HQ countrystring
Russia
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular diagnostics equipment, PCR reagent kits, real-time PCR instruments, DNA extraction kits, clinical laboratory diagnostics
Industry4 codes
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
NAICS code4 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
  • Medical Laboratories621511
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Laboratory Analytical Instruments3826
Product category
Molecular Diagnostics Equipment
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1PCR Equipment Sales
TypeHardware Sales
Description

Sale of real-time PCR instruments (DTprime, DTprime II, DTlite), PCR cabinets, DTstream dosing stations, DTpack microplate sealers, and general laboratory equipment.

dna-technology.com
2PCR and LAMP Reagent Kits
TypeOne Time License
Description

Sale of PCR detection kits for infectious diseases, genetics, microbiome analysis, HPV testing, and DNA/RNA extraction kits. Products include diagnostic kits for hepatitis, HIV, respiratory infections, sexually transmitted diseases, and other clinical applications.

dna-technology.com
3Transport Mediums
TypeOne Time License
Description

Sale of STOR-M and STOR-F transport mediums for biological sample collection and preservation.

dna-technology.com
4Software Licensing
TypeLicensing Royalties
Description

Licensing of DTmaster and RealTime software for PCR instruments, including assay library distribution packages with test parameters and modules.

dna-technology.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

DNA-Technology develops, manufactures, and supplies an integrated PCR-based molecular diagnostics ecosystem, comprising proprietary real-time PCR instruments (DTprime, DTprime II, DTlite), laboratory automation hardware (DTstream dosing stations, DTpack plate sealers, PCR cabinets), companion software (DTmaster, RealTime, DTintegrator), and an extensive portfolio of real-time PCR and LAMP reagent kits for infectious disease, HPV, microbiome, genetic, and pharmacogenetic testing, together with DNA/RNA extraction kits and transport media for clinical diagnostic and research laboratories.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Up to 800 samples can be dispensed during a workday
+3 more records
Product overview1 text field

DNA-Technology is a Russian molecular diagnostics company that has been developing, producing, and introducing high-tech PCR equipment and reagent kits since 1993. The company offers a comprehensive ecosystem for polymerase chain reaction (PCR) diagnostics comprising: (1) Hardware instruments including DTprime II, DTprime, and DTlite real-time PCR detection systems; (2) Software platforms DTmaster and RealTime for instrument control and assay management; (3) Laboratory automation solutions including DTstream dosing stations and DTintegrator software for integrated laboratory management; (4) An extensive portfolio of over 100 REAL-TIME PCR and LAMP reagent kits organized by application: intestinal infections (BacScreen AEI 1, BacScreen AEI 2, Shigella/EIEC/Salmonella), respiratory infections (SARS-CoV-2 variants, Influenza A/B, Bordetella, Legionella, M.tuberculosis), sexually transmitted diseases (Chlamydia, Gonorrhea, Trichomonas, Mycoplasma multiplex panels), hepatitis and HIV, herpesviruses, human papillomavirus (HPV QUANT-21, HPV QUANT-15, HPV QUANT-4, HPV 16/18 Multiplex), microbiome composition analysis (FEMOFLOR series for vaginal, Androflor for male, ParodontoScreen for oral), genetics and pharmacogenetics (BRCA, EGFR, cystic fibrosis, thrombophilia, pharmacogenetics for clopidogrel/warfarin), prenatal diagnosis (Fetal RHD Genotyping, Fetal Gender), HLA typing, antibiotic resistance detection (BacResista, MRS/MRSA), mycoses (MycosoScreen), and high-threat pathogens (Bacillus anthracis, Yersinia pestis, Vibrio cholerae); (5) DNA/RNA extraction kits (PREP-NA, PREP-GS, PREP-OPTIMA, PREP-MB MAX, PREP-RAPID series); (6) Transport media (STOR-M, STOR-F); (7) Supporting laboratory equipment (PCR cabinet, DTpack microplate sealer, DTmag-16S magnetic rack, DTtherm dry bath, DTspin centrifuge-vortex, Thermit thermostat). The system enables complete PCR workflow automation from sample preparation to result detection.

Product and service1 record
1DTprime II Real-Time PCR Instrument
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

DNA-Technology and the ITGEL Erüül Mend Clinic (Ulaanbaatar, Mongolia) have been working together for over a decade advancing modern molecular diagnostics technologies in Mongolia. This partnership represents a long-term strategic relationship focused on technology deployment and knowledge transfer in molecular diagnostics.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

GeneProof is a Czech-based molecular diagnostics company specializing in PCR and real-time PCR kits for infectious diseases, genetic testing, and HPV. Its product portfolio and CE-marked positioning in EMEA closely overlap DNA-Technology's diagnostic kit business.

TypeBroad incumbent
Description

QIAGEN's Rotor-Gene Q real-time PCR platform is a validated detection instrument for DNA-Technology's kits (HSV, Toxoplasma, Listeria). Both compete in nucleic acid extraction and PCR-based molecular diagnostics, with QIAGEN operating as a much larger global incumbent.

TypeBroad incumbent
Description

Bio-Rad is a major global life science and clinical diagnostics company whose CFX96 real-time PCR instrument is explicitly compatible with DNA-Technology's kits. Both serve clinical and research labs with PCR instruments and reagent kits, making Bio-Rad a direct technology-overlapping incumbent.

TypeBroad incumbent
Description

Thermo Fisher's QuantStudio 5 real-time PCR system is officially compatible with DNA-Technology's diagnostic kits. Both compete in real-time PCR instruments and assay kits for clinical and research applications, with Thermo Fisher serving as a global breadth incumbent.

TypeDirect peer
Description

Altona Diagnostics is a Hamburg-based molecular diagnostics company developing PCR kits for viral pathogens, including the AltoStar automation platform. It competes directly with DNA-Technology in real-time PCR reagent kits for infectious disease testing.

TypeBroad incumbent
Description

Roche is a dominant global diagnostics player with the LightCycler real-time PCR system and cobas molecular diagnostics platform. DNA-Technology competes in the same clinical PCR testing category, though Roche operates at vastly greater scale and global reach.

TypeBroad incumbent
Description

DiaSorin is an Italian diagnostics company with a molecular diagnostics business (including the Liaison MDX platform) and a broad IVD portfolio. It competes in clinical PCR and infectious disease testing where DNA-Technology offers reagent kits.

TypeBroad incumbent
Description

Cepheid's GeneXpert is a leading molecular diagnostics platform for infectious disease PCR testing. It is a broader incumbent in the molecular diagnostics category where DNA-Technology competes, though Cepheid specializes in cartridge-based closed systems rather than open PCR workflows.

9AmpliSens
TypeRegional player
Description

AmpliSens is a Russian/CIS-focused molecular diagnostics company producing PCR kits for infectious diseases and genetic testing. It is the most direct Russian-language competitor to DNA-Technology in the domestic CIS market.

TypeDirect peer
Description

ELITech is a European mid-market molecular diagnostics company manufacturing PCR instruments (e.g., InGenius, ELITe InGenius) and a broad range of PCR kits — closely matching DNA-Technology's product mix and target market of clinical diagnostic labs. Both companies operate at similar scale and focus on integrated PCR workflow solutions.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration8 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DNA‑Technology

Molecular Diagnostics Equipmentdna-technology.com

DNA-Technology is a Moscow-based molecular diagnostics manufacturer founded in 1993 that develops real-time PCR instruments, laboratory automation systems, and over 100 PCR/LAMP reagent kits for clinical diagnostic laboratories, hospitals, and research institutions across more than 50 countries.

What DNA‑Technology does

DNA-Technology LLC is a Moscow-based molecular diagnostics manufacturer founded in 1993 that develops, produces, and supplies PCR equipment, instruments, and consumables for clinical and research applications. The company serves clinical diagnostic laboratories, medical institutions and hospitals, and scientific research institutions, with a coverage of more than 50 distributors worldwide across Russia, Central Asia, Mongolia, and other regions. Its primary technology is polymerase chain reaction (PCR), including real-time PCR and LAMP (loop-mediated isothermal amplification), complemented by DNA/RNA extraction methodologies.

DNA‑Technology firmographics

Firmographics
Name
DNA‑Technology
Legal name
DNA-Technology LLC
Website
https://dna-technology.com
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
1–10 employees
Short description
DNA-Technology is a Moscow-based molecular diagnostics manufacturer founded in 1993 that develops real-time PCR instruments, laboratory automation systems, and over 100 PCR/LAMP reagent kits for clinical diagnostic laboratories, hospitals, and research institutions across more than 50 countries.
Ownership category
akta.pro rank

DNA‑Technology industry classification

Industry
Product category
Molecular Diagnostics Equipment
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories

Keywords

  • Molecular diagnostics equipment
  • PCR reagent kits
  • Real-time PCR instruments
  • DNA extraction kits
  • Clinical laboratory diagnostics

Where DNA‑Technology is headquartered

Location

Headquarters

HQ city
Moscow
HQ country
Russia
HQ region
Europe

Offices1 record

Markets served

DNA‑Technology business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. PCR Equipment Sales: Sale of real-time PCR instruments (DTprime, DTprime II, DTlite), PCR cabinets, DTstream dosing stations, DTpack microplate sealers, and general laboratory equipment.
  2. PCR and LAMP Reagent Kits: Sale of PCR detection kits for infectious diseases, genetics, microbiome analysis, HPV testing, and DNA/RNA extraction kits. Products include diagnostic kits for hepatitis, HIV, respiratory infections, sexually transmitted diseases, and other clinical applications.
  3. Transport Mediums: Sale of STOR-M and STOR-F transport mediums for biological sample collection and preservation.
  4. Software Licensing: Licensing of DTmaster and RealTime software for PCR instruments, including assay library distribution packages with test parameters and modules.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

DNA‑Technology product offering

Product offering

Core offering

DNA-Technology develops, manufactures, and supplies an integrated PCR-based molecular diagnostics ecosystem, comprising proprietary real-time PCR instruments (DTprime, DTprime II, DTlite), laboratory automation hardware (DTstream dosing stations, DTpack plate sealers, PCR cabinets), companion software (DTmaster, RealTime, DTintegrator), and an extensive portfolio of real-time PCR and LAMP reagent kits for infectious disease, HPV, microbiome, genetic, and pharmacogenetic testing, together with DNA/RNA extraction kits and transport media for clinical diagnostic and research laboratories.

Product overview

DNA-Technology is a Russian molecular diagnostics company that has been developing, producing, and introducing high-tech PCR equipment and reagent kits since 1993. The company offers a comprehensive ecosystem for polymerase chain reaction (PCR) diagnostics comprising: (1) Hardware instruments including DTprime II, DTprime, and DTlite real-time PCR detection systems; (2) Software platforms DTmaster and RealTime for instrument control and assay management; (3) Laboratory automation solutions including DTstream dosing stations and DTintegrator software for integrated laboratory management; (4) An extensive portfolio of over 100 REAL-TIME PCR and LAMP reagent kits organized by application: intestinal infections (BacScreen AEI 1, BacScreen AEI 2, Shigella/EIEC/Salmonella), respiratory infections (SARS-CoV-2 variants, Influenza A/B, Bordetella, Legionella, M.tuberculosis), sexually transmitted diseases (Chlamydia, Gonorrhea, Trichomonas, Mycoplasma multiplex panels), hepatitis and HIV, herpesviruses, human papillomavirus (HPV QUANT-21, HPV QUANT-15, HPV QUANT-4, HPV 16/18 Multiplex), microbiome composition analysis (FEMOFLOR series for vaginal, Androflor for male, ParodontoScreen for oral), genetics and pharmacogenetics (BRCA, EGFR, cystic fibrosis, thrombophilia, pharmacogenetics for clopidogrel/warfarin), prenatal diagnosis (Fetal RHD Genotyping, Fetal Gender), HLA typing, antibiotic resistance detection (BacResista, MRS/MRSA), mycoses (MycosoScreen), and high-threat pathogens (Bacillus anthracis, Yersinia pestis, Vibrio cholerae); (5) DNA/RNA extraction kits (PREP-NA, PREP-GS, PREP-OPTIMA, PREP-MB MAX, PREP-RAPID series); (6) Transport media (STOR-M, STOR-F); (7) Supporting laboratory equipment (PCR cabinet, DTpack microplate sealer, DTmag-16S magnetic rack, DTtherm dry bath, DTspin centrifuge-vortex, Thermit thermostat). The system enables complete PCR workflow automation from sample preparation to result detection.

Differentiator

Problem solved

Functional benefit

Products and services

  • DTprime II Real-Time PCR Instrument

Quantifiable outcome

  • Up to 800 samples can be dispensed during a workday
  • +3 more outcomes

Companies that use DNA‑Technology

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

DNA‑Technology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration8 records

Feature9 records

DNA‑Technology partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • ITGEL Erüül Mend CliniccoreStrategic or Co-development Partner · 1 January 2024DNA-Technology and the ITGEL Erüül Mend Clinic (Ulaanbaatar, Mongolia) have been working together for over a decade advancing modern molecular diagnostics technologies in Mongolia. This partnership represents a long-term strategic relationship focused on technology deployment and knowledge transfer in molecular diagnostics.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

DNA‑Technology competitors and assessment

Company assessment

Direct peers

  • GeneProof: GeneProof is a Czech-based molecular diagnostics company specializing in PCR and real-time PCR kits for infectious diseases, genetic testing, and HPV. Its product portfolio and CE-marked positioning in EMEA closely overlap DNA-Technology's diagnostic kit business.
  • Altona Diagnostics: Altona Diagnostics is a Hamburg-based molecular diagnostics company developing PCR kits for viral pathogens, including the AltoStar automation platform. It competes directly with DNA-Technology in real-time PCR reagent kits for infectious disease testing.
  • ELITech Group: ELITech is a European mid-market molecular diagnostics company manufacturing PCR instruments (e.g., InGenius, ELITe InGenius) and a broad range of PCR kits — closely matching DNA-Technology's product mix and target market of clinical diagnostic labs. Both companies operate at similar scale and focus on integrated PCR workflow solutions.

Broad incumbents

  • QIAGEN: QIAGEN's Rotor-Gene Q real-time PCR platform is a validated detection instrument for DNA-Technology's kits (HSV, Toxoplasma, Listeria). Both compete in nucleic acid extraction and PCR-based molecular diagnostics, with QIAGEN operating as a much larger global incumbent.
  • Bio-Rad Laboratories: Bio-Rad is a major global life science and clinical diagnostics company whose CFX96 real-time PCR instrument is explicitly compatible with DNA-Technology's kits. Both serve clinical and research labs with PCR instruments and reagent kits, making Bio-Rad a direct technology-overlapping incumbent.
  • Thermo Fisher Scientific (Applied Biosystems): Thermo Fisher's QuantStudio 5 real-time PCR system is officially compatible with DNA-Technology's diagnostic kits. Both compete in real-time PCR instruments and assay kits for clinical and research applications, with Thermo Fisher serving as a global breadth incumbent.
  • Roche Diagnostics: Roche is a dominant global diagnostics player with the LightCycler real-time PCR system and cobas molecular diagnostics platform. DNA-Technology competes in the same clinical PCR testing category, though Roche operates at vastly greater scale and global reach.
  • DiaSorin: DiaSorin is an Italian diagnostics company with a molecular diagnostics business (including the Liaison MDX platform) and a broad IVD portfolio. It competes in clinical PCR and infectious disease testing where DNA-Technology offers reagent kits.
  • Cepheid (Danaher): Cepheid's GeneXpert is a leading molecular diagnostics platform for infectious disease PCR testing. It is a broader incumbent in the molecular diagnostics category where DNA-Technology competes, though Cepheid specializes in cartridge-based closed systems rather than open PCR workflows.

Regional players

  • AmpliSens: AmpliSens is a Russian/CIS-focused molecular diagnostics company producing PCR kits for infectious diseases and genetic testing. It is the most direct Russian-language competitor to DNA-Technology in the domestic CIS market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

DNA‑Technology social profiles

Digital presence

DNA‑Technology compliance and trust

Trust signal

Compliance8 records

DNA‑Technology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DNA‑Technology leadership team

Management profile

Number of profiles

DNA‑Technology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DNA‑Technology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DNA‑Technology

What does DNA‑Technology do?

DNA-Technology develops, manufactures, and supplies an integrated PCR-based molecular diagnostics ecosystem, comprising proprietary real-time PCR instruments (DTprime, DTprime II, DTlite), laboratory automation hardware (DTstream dosing stations, DTpack plate sealers, PCR cabinets), companion software (DTmaster, RealTime, DTintegrator), and an extensive portfolio of real-time PCR and LAMP reagent kits for infectious disease, HPV, microbiome, genetic, and pharmacogenetic testing, together with DNA/RNA extraction kits and transport media for clinical diagnostic and research laboratories.

Is DNA‑Technology a public or private company?

DNA‑Technology is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was DNA‑Technology founded?

DNA‑Technology was founded in 1993. It employs 1 to 10 people.

Where is DNA‑Technology based?

DNA‑Technology is headquartered in Moscow, Russia, in the Europe region.

How does DNA‑Technology make money?

Four revenue lines are on record. PCR Equipment Sales are the primary driver. The others are PCR and LAMP Reagent Kits, transport Mediums and software Licensing.

Who are DNA‑Technology's main competitors?

Direct peers on record are GeneProof, Altona Diagnostics and ELITech Group. Broad incumbents are QIAGEN, Bio-Rad Laboratories, Thermo Fisher Scientific (Applied Biosystems), Roche Diagnostics, DiaSorin and Cepheid (Danaher). AmpliSens is listed as a regional player.

Does DNA‑Technology have an API?

No public API is recorded for DNA‑Technology.

What industry is DNA‑Technology in?

DNA‑Technology's product category is Molecular Diagnostics Equipment. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals